ABSTRACT
BACKGROUND: It was demonstrated that external stress, such as in vitro maturation (IVM) and vitrification process can induce significantly reduced development capacity in oocytes. Previous studies indicated that antioxidants play a pivotal part in the acquisition of adaptation in changed conditions. At present, the role of the natural potent antioxidant PCB2 in response to IVM and vitrification during ovine oocyte manipulation has not been explored. OBJECTIVE: To investigate whether PCB2 treatment could improve the developmental potential of ovine oocytes under IVM and vitrification stimuli. MATERIALS AND METHODS: The experiment was divided into two parts. Firstly, the effect of PCB2 on the development of oocytes during IVM was evaluated. Un-supplemented and 5 ug per mL PCB2-supplemented in the IVM solution were considered as control and experimental groups (C + 5 ug per mL PCB2). The polar body extrusion (PBE) rate, mitochondrial membrane potential (MMP), ATP, reactive oxygen species (ROS) levels and early apoptosis of oocytes were measured after IVM. Secondly, we further determine whether PCB2 could improve oocyte quality under vitrification stress. The survival rate, PBE rate and early apoptosis of oocytes were compared between fresh group, vitrified group and 5 ug per mL PCB2-supplemented in the IVM solution after vitrification (V + 5 ug per mL PCB2). RESULTS: Compared to the control group, adding PCB2 significantly increased PBE rate (79.4% vs. 62.8%, P < 0.01) and MMP level (1.9 +/- 0.08 vs. 1.3 +/- 0.04, P < 0.01), and decreased ROS level (47.1 +/- 6.3 vs. 145.3 +/- 8.9, P < 0.01). However, there was no significant difference in ATP content and early apoptosis. Compared to the fresh group, vitrification significantly reduced oocytes viability (43.0% vs. 90.8%, P < 0.01) as well as PBE rate (24.2% vs. 60.6%, P < 0.05). However, 5 ug per mL PCB2-supplemention during maturation had no effect on survival, PBE or early apoptosis in vitrified oocytes. CONCLUSION: PCB2 could effectively antagonise the oxidative stress during IVM and promote oocyte development. DOI: 10.54680/fr23210110412.
Subject(s)
Antioxidants , Vitrification , Sheep , Animals , Antioxidants/pharmacology , Cryopreservation , Reactive Oxygen Species , Oocytes/physiology , Sheep, Domestic , Adenosine Triphosphate/pharmacology , In Vitro Oocyte Maturation TechniquesABSTRACT
This study aims to observe the efficacy of supplemented Er-xian decoction combined with acupoint application in treating poor ovarian response (POR). This study was a randomized controlled trial. A total of 80 patients, who were treated in the Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine from January 2016 to December 2017, were divided into two groups by tables of random numbers: experimental group (n = 40), and control group (n = 40). In the experimental group, patients orally received supplemented Er-xian decoction with acupoint application. In the control group, a Kuntai capsule was administered according to the course of treatment. The therapeutic effects in the two groups were observed and compared. In the experimental group, the total effective rate was 90%, the cure rate was 15% (six patients), the markedly effective rate was 35% (14 patients), the effective rate was 40% (16 patients), and the ineffective rate was 10% (four patients). In the control group, the total effective rate was 50%, the cure rate was 5% (two patients), the markedly effective rate was 15% (six patients), the effective rate was 30% (12 patients), and the ineffective rate was 50% (20 patients). The differences were statistically significant (P > 0.05). Definite efficacy was observed when a poor ovarian response was treated by supplemented Er-xian decoction combined with acupoint application. Improvements in perimenopausal symptoms, menstruation conditions, hormone levels, inhibin B (INHB), and antral follicle count (AFC) were markedly better in the experimental group than in the control group. In addition, the treatment was safe and had few side effects.
Subject(s)
Acupuncture Points , Drugs, Chinese Herbal/therapeutic use , Fertilization in Vitro/methods , Ovarian Neoplasms/therapy , Ovulation/drug effects , Adult , Female , Follicle Stimulating Hormone/metabolism , Humans , Ovarian Neoplasms/metabolism , Ovarian Neoplasms/pathology , Reproductive Health , Treatment OutcomeABSTRACT
Protein purification often involves affinity capture of proteins on stationary resin, alternatively proteins are captured on free flowing resin for subsequent separation from bulk fluid. Both methods require labour and time intensive separation of particulate matter from fluid. We present a method where affinity resin is contained within porous-walled containers, supporting clarification, product recovery, and concentration in a single step with minimal hands-on processing time, without significant investments in equipment.
Subject(s)
Chromatography, Affinity/methods , Proteins/isolation & purification , Animals , CHO Cells , Chromatography, Affinity/instrumentation , Cricetinae , Cricetulus , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/isolation & purification , Green Fluorescent Proteins/metabolism , HEK293 Cells , Humans , Immobilized Proteins/chemistry , Immobilized Proteins/metabolism , Porosity , Proteins/genetics , Proteins/metabolism , Tea/chemistryABSTRACT
OBJECTIVE: To approach a new evidence for identifying various species of Rosaceae Sanguisorba, especially for distinguishing S. applanata from S. sitchinese. METHOD: The pollens of five species S. officinalis, S. officinalis var. longifolia, S. applanata, S. applanata var. villosa and S. sitchinese were morphologically identified with electron microscope. RESULTS: The pollens are prolate or perprolate, having six colporates and featuring sculptures of small caverns and small granules combined. The species are closed to each other in pollen morphology, bur display differences in the diameter of pollens, clarity of pore membrane and presence or absence of irregular verrucous sculptures. CONCLUSION: This paper provides a new evidence for identifying the Sanguisorba.
Subject(s)
Plants, Medicinal , Pollen/ultrastructure , Sanguisorba , Microscopy, Electron, Scanning , Pharmacognosy , Plants, Medicinal/classification , Plants, Medicinal/ultrastructure , Sanguisorba/classification , Sanguisorba/ultrastructureABSTRACT
The authors report that the karyotype formula of Eclipta prostrata is K(2n) = 22 = 16m + 6sm, which belongs to "1A" of stebbins, the chromosome composition based on relative length is 2n = 22 = 10M2 + 12M1, and the total length of the chromosome is 29.3 microns. The chromosome volume of E. prostrata has also been calculated.